Found 1 articles for: "JAK Inhibitor Safety"

JAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies
December 2022 | Volume 21 | Issue 12 | Original Article | 1298 | Copyright © December 2022
Dermatologists treating atopic dermatitis are interested in the safety profile of the recently available JAK inhibitors, upadacitinib and abrocitinib, especially after they received boxed safety warni...
Read More

© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

Found 1 articles for: "JAK Inhibitor Safety"

JAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies

December 2022 | Volume 21 | Issue 12 | Original Article | 1298 | Copyright © December 2022

Search page

Advertisement

Popular

Advertisement

News Topics

News Topics

Journal of Drugs in Dermatology

Search